- Home
- HMST vs STXS Comparison
HMST vs STXS Comparison
Compare HMST & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- STXS
- Stock Information
- Founded
- HMST 1921
- STXS 1990
- Country
- HMST United States
- STXS United States
- Employees
- HMST N/A
- STXS N/A
- Industry
- HMST Major Banks
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HMST Finance
- STXS Health Care
- Exchange
- HMST Nasdaq
- STXS Nasdaq
- Market Cap
- HMST 246.0M
- STXS 151.3M
- IPO Year
- HMST 2012
- STXS 2004
- Fundamental
- Price
- HMST $13.14
- STXS $2.17
- Analyst Decision
- HMST Hold
- STXS
- Analyst Count
- HMST 3
- STXS 0
- Target Price
- HMST $14.17
- STXS N/A
- AVG Volume (30 Days)
- HMST 66.7K
- STXS 270.0K
- Earning Date
- HMST 07-28-2025
- STXS 08-11-2025
- Dividend Yield
- HMST N/A
- STXS N/A
- EPS Growth
- HMST N/A
- STXS N/A
- EPS
- HMST N/A
- STXS N/A
- Revenue
- HMST $78,454,000.00
- STXS $27,510,000.00
- Revenue This Year
- HMST $161.80
- STXS $25.90
- Revenue Next Year
- HMST $8.90
- STXS $60.57
- P/E Ratio
- HMST N/A
- STXS N/A
- Revenue Growth
- HMST N/A
- STXS 1.50
- 52 Week Low
- HMST $8.41
- STXS $1.54
- 52 Week High
- HMST $16.10
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- HMST 50.08
- STXS 52.27
- Support Level
- HMST $12.05
- STXS $2.00
- Resistance Level
- HMST $12.84
- STXS $2.36
- Average True Range (ATR)
- HMST 0.34
- STXS 0.11
- MACD
- HMST -0.08
- STXS -0.01
- Stochastic Oscillator
- HMST 27.34
- STXS 50.00
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.